Open Payments Database Notice

Research & Publications

Thyroid eye disease patients report maintained improvement 2 years after teprotumumab infusions

A Prospective Study Examining Audiometry Outcomes Following Teprotumumab Treatment for Thyroid Eye Disease

Teprotumumab for the Treatment of Active Thyroid Eye Disease

Teprotumumab for the treatment of Thyroid eye disease

Teprotumumab improves light sensitivity in patients with thyroid eye disease

Teprotumumab Efficacy, Safety, and Durability in Longer-Duration Thyroid Eye Disease and Re-treatment

Facial and Eyelid Changes in Thyroid Eye Diseases Are Reversed by Teprotumumab

Efficacy and Safety of Teprotumumab in Patients With Thyroid Eye Disease of Long Duration and Low Disease Activity